Navigating the world is no mean feat, especially when the world pushes back. For instance, airflow hitting a fly on its right ...

The research, funded in part by the National Institutes of Health and published Jan. 21 in Nature, showed that deoxyhypusine ...

Sino Biological, Inc. is proud to announce the launch of its innovative SwiftFluo TR-FRET Kinase Assay Kits, a ready-to-use, high-performance solution designed to accelerate kinase activity detection ...

The tumor microenvironment (TME) is a metabolically dynamic niche where cancer cells and immune cells interact to influence tumor progression and immune ...

Researchers have uncovered a stealthy way pancreatic cancer disarms the immune system, using tiny molecular messengers to ...

Complex sugar-protein molecules that sense external messages to help a cell grow or respond to its environment can now be ...

Since its introduction by Polly Matzinger, the Danger Theory has profoundly reshaped modern immunology. Rather than relying solely on a self/non-self ...

Kincell Bio, a leading contract development and manufacturing organization (CDMO) in cell therapy, is pleased to announce the promotion of Lawrence “Larry” Pitcher to Chief Executive Officer, ...

– New collaboration builds on Sanofi’s prior acquisition of DR-0201 and further leverages Dren Bio’s proprietary Targeted Myeloid Engager and Phagocytosis Platform to discover first-in-class ...

Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...

After an illness like the flu, symptoms may go away while a person still feels lousy. Researchers wanted to learn more about this state, and how people who are recovering from illnesses can be ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. Down the line, Adagene could make up to $840 million in development and commercial ...